E72.54 Category · further specificity required Secondary hyperoxaluria
ICD-10-CM E72.54 identifies “Secondary hyperoxaluria” as a category requiring further specificity in the FY2027 U.S. classification, effective October 1, 2026 through September 30, 2027.
Chapter 4: Endocrine, nutritional and metabolic diseases
Code-level instructions
Excludes 11
primary hyperoxaluria (E72.53-)
Inherited instructions
Chapters 4 · Endocrine, nutritional and metabolic diseases (E00-E89)
Excludes 11
transitory endocrine and metabolic disorders specific to newborn (P70-P74)
Note1
All neoplasms, whether functionally active or not, are classified in Chapter 2. Appropriate codes in this chapter (i.e. E05.8, E07.0, E16-E31, E34.-) may be used as additional codes to indicate either functional activity by neoplasms and ectopic endocrine tissue or hyperfunction and hypofunction of endocrine glands associated with neoplasms and other conditions classified elsewhere.
E70-E88 · Metabolic disorders (E70-E88)
Excludes 15
Excludes 21
Ehlers-Danlos syndromes (Q79.6-)
E72 · Other disorders of amino-acid metabolism
More specific codes
Official index references
References from other codes (2)
Excludes 1 · secondary hyperoxaluria (E72.54-)
Excludes 1 · secondary hyperoxaluria (E72.54-)
History
Code history
Latest recorded change · FY2026
Effective from
- Added
Secondary hyperoxaluria
Category — select a more specific code
CDC/NCHS · FY2026All editions (3)
| All editions | Effective from | Code history |
|---|---|---|
| FY2026 | 2025-10-01 | Added |
| FY2026 · April | 2026-04-01 | No tabular change |
| FY2027 | 2026-10-01 | No tabular change |
Explore the more specific codes in this category. Reference checks do not establish clinical appropriateness or guarantee reimbursement.